Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michio Hongo

Showing results (31-40 of 239) with videos related to

Pageof 24
Sort By:
Journal of Gastroenterology|November 18, 2010
Effect of rabeprazole treatment on health-related quality of life and symptoms in patients with reflux esophagitis: a prospective multicenter observational study in JapanMichio Hongo, Hiroto Miwa, Motoyasu Kusano, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitorsMichio Hongo, Hiroto Miwa, Motoyasu Kusano, et al.
Digestive Diseases and Sciences|February 9, 2011
Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic studyKiyoshi Ashida, Yoshikazu Kinoshita, Michio Hongo, et al.
Osteoporosis and Sarcopenia|April 19, 2021
Long-term changes in lean mass in postmenopausal women and the effects of osteoporosis pharmacotherapy: A 10-year longitudinal studyNaohisa Miyakoshi, Michio Hongo, Yoichi Shimada
Journal of Gastroenterology|November 2, 2011
Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitisHiroto Miwa, Michio Hongo, Motoyasu Kusano, et al.
Journal of Gastroenterology|July 5, 2008
A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux diseaseMichio Hongo, Yoshikazu Kinoshita, Ken Haruma
Journal of Gastroenterology and Hepatology|August 4, 2009
Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicityMichio Hongo, Yutaka Nagasaki, Tomotaka Shoji
BMC Surgery|July 5, 2015
En-bloc resection of thoracic calcified meningioma with inner dural layer in recapping T-saw laminoplasty: a case reportNaohisa Miyakoshi, Michio Hongo, Yuji Kasukawa, et al.
Journal of Gastroenterology|June 23, 2011
Systematic review of the epidemiology of gastroesophageal reflux disease in JapanYoshikazu Kinoshita, Kyoichi Adachi, Michio Hongo, et al.
Journal of Medical Economics|August 21, 2009
Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOLMichio Hongo, Yoshikazu Kinoshita, Hiroto Miwa, et al.
Pageof 24

Showing results (31-40 of 239) with videos related to

Sort By:
Pageof 24
Journal of Gastroenterology|November 18, 2010
Effect of rabeprazole treatment on health-related quality of life and symptoms in patients with reflux esophagitis: a prospective multicenter observational study in JapanMichio Hongo, Hiroto Miwa, Motoyasu Kusano, et al.
Journal of Gastroenterology and Hepatology|December 7, 2011
Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitorsMichio Hongo, Hiroto Miwa, Motoyasu Kusano, et al.
Digestive Diseases and Sciences|February 9, 2011
Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic studyKiyoshi Ashida, Yoshikazu Kinoshita, Michio Hongo, et al.
Osteoporosis and Sarcopenia|April 19, 2021
Long-term changes in lean mass in postmenopausal women and the effects of osteoporosis pharmacotherapy: A 10-year longitudinal studyNaohisa Miyakoshi, Michio Hongo, Yoichi Shimada
Journal of Gastroenterology|November 2, 2011
Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitisHiroto Miwa, Michio Hongo, Motoyasu Kusano, et al.
Journal of Gastroenterology|July 5, 2008
A randomized, double-blind, placebo-controlled clinical study of the histamine H2-receptor antagonist famotidine in Japanese patients with nonerosive reflux diseaseMichio Hongo, Yoshikazu Kinoshita, Ken Haruma
Journal of Gastroenterology and Hepatology|August 4, 2009
Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicityMichio Hongo, Yutaka Nagasaki, Tomotaka Shoji
BMC Surgery|July 5, 2015
En-bloc resection of thoracic calcified meningioma with inner dural layer in recapping T-saw laminoplasty: a case reportNaohisa Miyakoshi, Michio Hongo, Yuji Kasukawa, et al.
Journal of Gastroenterology|June 23, 2011
Systematic review of the epidemiology of gastroesophageal reflux disease in JapanYoshikazu Kinoshita, Kyoichi Adachi, Michio Hongo, et al.
Journal of Medical Economics|August 21, 2009
Characteristics affecting health-related quality of life (HRQOL) in Japanese patients with reflux oesophagitis and the effect of lansoprazole on HRQOLMichio Hongo, Yoshikazu Kinoshita, Hiroto Miwa, et al.
Pageof 24